# DeepLife

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deeplife

- Industry: Biotechnology
- Headquarters: France
- Website: www.deeplife.co/
- Total disclosed funding: $12M
- Latest round: Series A (Dec 11, 2024)
- Investors on record: 9

## About

Based in France, DeepLife SAS DeepLife is a biotechnology company specializing in leveraging artificial intelligence and multi-omics data to model cellular behaviors and engineer cellular systems. In December 2024, DeepLife SAS raised USD 10 million in series A funding co-led by new investors YZR and Relyens, with participation from other new investors Beiersdorf AG and Prunay Group. The company was founded by Jonathan Baptista (CEO), and Jean-Baptiste Morlot.

DeepLife offers a suite of products designed to facilitate drug discovery and cellular research. Their primary offerings include DeepLife Datastore™ which is a comprehensive multi-omics database providing access to harmonized datasets from over 30 qualified data repositories. Additionally, it provides DeepLife Analysis™ tools for analyzing and interpreting complex biological data as well as DeepLife Virtual Cell™ which is a simulation platform that creates digital twins of cells to explore and manipulate their behavior in silico.

## Funding rounds

- Series A, Dec 11, 2024, $10M — Beiersdorf AG, Relyens, Prunay Group, YZR
- Seed, Sep 22, 2022, $1.8M — Bpifrance, Kima Ventures, Mid Atlantic Bio Angels, Entrepreneur First, Paris Business Angels

## Investors

- Bpifrance — Seed
- Kima Ventures (https://capitalatlas.ai/funds/kima-ventures) — Seed
- Mid Atlantic Bio Angels (https://capitalatlas.ai/funds/mid-atlantic-bio-angels) — Seed
- Entrepreneur First (https://capitalatlas.ai/funds/entrepreneur-first) — Seed
- Paris Business Angels (https://capitalatlas.ai/funds/paris-business-angels) — Seed
- Beiersdorf AG — Series A
- Relyens — Series A
- Prunay Group — Series A
- YZR (https://capitalatlas.ai/funds/yzr) — Series A